FDA Contracting With Business That Allegedly Profited From Selling Aborted Babies’ Tissue

The U.S. Food and Drug Administration (FDA) has contracted with a company that reportedly has sold aborted baby tissue for profit.

As CNS News reported, the FDA signed a one-year, $15,900 contract with Advanced Bioscience Resources in order to obtain babies’ fetal tissue “for implantation into severely immune-compromised mice to create chimeric animals that have a human immune system.” As Melanie Israel of The Daily Signal reports, “According to the government’s presolicitation notice, ‘ABR is the only company in the U.S. capable of supplying’ the fetal tissue and ‘no other company or organization is capable of fulfilling the need.’”